Bora Pharmaceuticals Co. Ltd., a pharmaceutical manufacturer, has completed its acquisition of Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland—adding drug product fill/finish to its biologics drug substance capabilities.   The newly acquired 87,000-sq. ft. facility provides drug product manufacturing services for sterile injectables. It offers clinical and commercial non-viral aseptic fill/finish services of vials and pre-filled syringes on four fill lines, ...